Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment
Introduction: Female pattern hair loss (FPHL) is one of the most common forms of diffuse alopecia in females.. Despite the availability of multiple treatment options, FPHL management poses challenges for the dermatologist. Objectives: We aimed to compare the efficacy and safety of topical finaste...
Saved in:
Main Authors: | Naglaa Mohamed El Sayed, Eman Hamed Elmorsy, Tarek Mahmoud Hussein, Eman Hassan |
---|---|
Format: | Article |
Language: | English |
Published: |
Mattioli1885
2025-01-01
|
Series: | Dermatology Practical & Conceptual |
Subjects: | |
Online Access: | https://dpcj.org/index.php/dpc/article/view/4698 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral Finasteride (5 mg and 2 mg) versus Topical Minoxidil 5% in Female Pattern Hair Loss
by: Eman Hamed El Morsy, et al.
Published: (2025-01-01) -
A Systematic Review of Spironolactone Nano-Formulations for Topical Treatment of Skin Hyperandrogenic Disorders and Chronic Wounds
by: Saedah Dereiah, et al.
Published: (2024-12-01) -
Effectiveness of autologous growth factor concentrates combined with topical minoxidil in patients of androgenic alopecia
by: Lavanya Maripati, et al.
Published: (2025-01-01) -
Change in hair growth-related gene expression profile in human isolated hair follicles induced by 5-alpha reductase inhibitors – dutasteride and finasteride – in the presence of testosterone
by: Toshiki Hatanaka, et al.
Published: (2022-09-01) -
The antihypertensive efficacy of a quadruple single-pill combination in patients with resistant hypertension: study protocol for a randomized, open-label, crossover trial
by: Yuanyuan Yao, et al.
Published: (2025-01-01)